MedPath

The New York State Psychiatric Institute

The New York State Psychiatric Institute logo
🇺🇸United States
Ownership
Private
Established
1895-01-01
Employees
251
Market Cap
-
Website
http://www.nyspi.org

Tianeptine for Treatment Resistant Depression

Phase 4
Recruiting
Conditions
Treatment Resistant Depression
Interventions
First Posted Date
2020-01-31
Last Posted Date
2024-07-03
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
75
Registration Number
NCT04249596
Locations
🇺🇸

Mood and Anxiety Disorders Program at the Icahn School of Medicine at Mount Sinai, New York, New York, United States

🇺🇸

Stanford Depression Research Clinic at Stanford University School of Medicine, Stanford, California, United States

🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Using mHealth to Optimize Pharmacotherapy Regimens

Not Applicable
Completed
Conditions
Schizophrenia
First-Episode Psychosis
Interventions
Other: mHealth Intervention
First Posted Date
2020-01-30
Last Posted Date
2024-05-01
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
23
Registration Number
NCT04248517
Locations
🇺🇸

Lenox Hill Hospital, New York, New York, United States

🇺🇸

Bestself Behavioral Health, Inc., Buffalo, New York, United States

🇺🇸

Institute for Family Health, New York, New York, United States

and more 1 locations

Treating Self Injurious Behavior: A Novel Brain Stimulation Approach

Not Applicable
Completed
Conditions
Self-Injurious Behavior
Non Suicidal Self Inflicted Injury
Self Harm
Non-Suicidal Self Injury
Self-inflicted Injury
Self Injurious Behavior Without Suicidal Intent
Depression
Bipolar Disorder
Borderline Personality Disorder
Self-injury
Interventions
Device: Transcranial direct current stimulation
Other: No intervention
First Posted Date
2020-01-28
Last Posted Date
2024-07-03
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
13
Registration Number
NCT04244786
Locations
🇺🇸

New York State Psychiatric Institute/Columbia University, New York, New York, United States

Anti-suicidal Effects of Buprenorphine in Opioid Use Disorder

Phase 4
Withdrawn
Conditions
Opioid-use Disorder
Suicidal Ideation
Interventions
Drug: Buprenorphine/Naloxone 8/2 milligram (mg) Sublingual Film
First Posted Date
2020-01-21
Last Posted Date
2021-06-18
Lead Sponsor
New York State Psychiatric Institute
Registration Number
NCT04234516
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Facilitating Opioid Care Connections

Not Applicable
Active, not recruiting
Conditions
Opioid Court Model
Medication to Treat Opioid Use Disorder
Opioid Use
Interventions
Behavioral: OCM-RISE
First Posted Date
2020-01-03
Last Posted Date
2025-04-09
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
3440
Registration Number
NCT04216719
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Suicide Prevention in Prepubertal Children

Not Applicable
Withdrawn
Conditions
Suicide, Attempted
Suicidal Ideation
Interventions
Behavioral: Child- Safety Plan Intervention
First Posted Date
2019-11-20
Last Posted Date
2024-01-05
Lead Sponsor
New York State Psychiatric Institute
Registration Number
NCT04171089
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Eye Tracking as a Biomarker of Cannabis Effects

Phase 2
Terminated
Conditions
Cannabis Use
Pain, Acute
Interventions
First Posted Date
2019-09-24
Last Posted Date
2022-06-30
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
1
Registration Number
NCT04100590
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Investigating the Effect of Dronabinol on Post-surgical Pain

Early Phase 1
Withdrawn
Conditions
Knee Replacement
Arthropathy of Knee
Interventions
Drug: Non-active comparator
First Posted Date
2019-09-23
Last Posted Date
2023-11-13
Lead Sponsor
New York State Psychiatric Institute
Registration Number
NCT04099355
Locations
🇺🇸

1051 Riverside Drive, New York, New York, United States

Ketamine Treatment Effects on Synaptic Plasticity in Depression

Phase 4
Completed
Conditions
Major Depressive Disorder
Interventions
First Posted Date
2019-09-17
Last Posted Date
2023-11-13
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
9
Registration Number
NCT04091971
Locations
🇺🇸

New York State Psychiatric Institute/Columbia University, New York, New York, United States

The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking

Phase 2
Recruiting
Conditions
Alcohol Use Disorder
Interventions
Behavioral: MBRP
Behavioral: MET
First Posted Date
2019-09-10
Last Posted Date
2023-11-07
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
120
Registration Number
NCT04084860
Locations
🇺🇸

NYSPI, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath